Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4369368 | 0.86 | ALDH1A1 (0.40) | TSHRLMNACYP2A6KCNN4ALDH1A1 | |
| SCHEMBL4373436 | 0.82 | ALDH1A1 (0.40) | TSHRLMNAKCNN4ALDH1A1ALOX12 | |
| SCHEMBL434410 | 0.79 | — | — | |
| SCHEMBL28919218 | 0.75 | TSHR (0.45) | TSHRLMNACYP2A6KCNN4ALDH1A1 | |
| SCHEMBL752807 | 0.75 | ACHE (0.45) | TSHRLMNACYP2A6ALDH1A1ALOX12 | |
| SCHEMBL29908244 | 0.75 | TSHR (0.45) | TSHRLMNACYP2A6KCNN4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL4369366 | 0.73 | ACHE (0.43) | TSHRLMNACYP2A6ALDH1A1ALOX12 | |
| SCHEMBL154107 | 0.73 | ALDH1A1 (0.40) | TSHRLMNAALDH1A1ALOX12L3MBTL1 | |
| SCHEMBL753567 | 0.71 | TSHR (0.41) | TSHRLMNACYP2A6ALDH1A1ALOX12 | |
| SCHEMBL3626521 | 0.71 | TSHR (0.41) | TSHRLMNACYP2A6ALDH1A1ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3698140-A1 | METHODS FOR MONITORING BLADDER CANCER IMMUNOTHERAPY | NantBio, Inc. (US) | 2020-08-26 | — | — | EP | claimed |
| WO-2019079009-A1 | METHODS FOR MONITORING BLADDER CANCER IMMUNOTHERAPY | NANTBIO, INC. (US) | 2019-04-25 | — | — | WO | claimed |
| US-20190117153-A1 | METHODS FOR MONITORING BLADDER CANCER IMMUNOTHERAPY | NANTBIO, INC. | 2019-04-25 | — | — | US | claimed |
| EP-2046767-B1 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | PROVENCE TECHNOLOGIES (FR) | 2015-04-22 | — | — | EP | claimed |
| US-8765942-B2 | Process for preparing diaminophenothiazinium compounds | PROVENCE TECHNOLOGIES (FR) | 2014-07-01 | — | — | US | claimed |
| US-20140123718-A1 | LIQUID PHOSPHATE FERTILIZER SOLUTION FOR AGRONOMIC USE | ANTELO JOSÉ RAMÓN FLORENCIO (AR) | 2014-05-08 | — | — | US | claimed |
| WO-2012012656-A2 | MATERIALS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | UNIVERSITY OF SOUTH FLORIDA (US) | 2012-01-26 | — | — | WO | claimed |
| US-20090291943-A1 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | PROVEPHARM LIFE SOLUTIONS (FR) | 2009-11-26 | — | — | US | claimed |
| US-4361561-A | METHYLENE BLUE | Naylor, Graham John (GB) | 1982-11-30 | — | — | US | claimed |
| US-12576140-B2 | Cyclophilin 40 for reduction of neurotoxic fibrils and treatment of neurodegenerative diseases | UNIVERSITY OF SOUTH FLORIDA (US) | 2026-03-17 | — | — | US | disclosed |
| EP-4017496-B1 | FORMULATIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF PERIPHERAL NEUROPATHY AND ITS ASSOCIATED DISEASES | LOH YIN SZE (SG) | 2026-01-07 | — | — | EP | disclosed |
| US-20250367466-A1 | LIGHT THERAPY BED WITH ILLUMINATED MESH SUPPORT STRUCTURE | POWER MEDICINE LLC (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250332177-A1 | Methylene Blue COVID-19 Composition | FRIKHA DORRA (US) | 2025-10-30 | — | — | US | disclosed |
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-10-23 | — | — | US | disclosed |
| US-5353449-A | Toilet training method | TINKLE MAGIC, INC. (US) | 1994-10-11 | — | — | US | disclosed |
| US-4548927-A | Method and agents for raising animal tolerance to oxidant stress-inducing antibiotics | EATON JOHN W (US) | 1985-10-22 | — | — | US | disclosed |
| EP-0144402-A1 | METHOD AND AGENTS FOR RAISING ANIMAL TOLERANCE TO OXIDANT STRESS-INDUCING ANTIBIOTICS | EATON, John W. (US) | 1985-06-19 | — | — | EP | disclosed |
| WO-1984004679-A1 | METHOD AND AGENTS FOR RAISING ANIMAL TOLERANCE TO OXIDANT STRESS-INDUCING ANTIBIOTICS | EATON JOHN W | 1984-12-06 | — | — | WO | disclosed |
| US-4414212-A | Method of treatment of pre-menstrual syndrome | Naylor, Graham J. (GB) | 1983-11-08 | — | — | US | disclosed |
| US-4361561-A | METHYLENE BLUE | Naylor, Graham John (GB) | 1982-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | TSHR 1453/4885LMNA 222/4885CYP2A6 1042/4885 |
| US-12576140-B2 | Cyclophilin 40 for reduction of neurotoxic fibrils and treatment of neurodegenerative diseases | PSEN1, PSEN2, PRNP | TSHR 2889/4885LMNA 383/4885CYP2A6 3521/4885 |
| US-20090291943-A1 | PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS | DCPS, QDPR, DNPEP | TSHR 3603/4885LMNA 2709/4885CYP2A6 851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.